• Citer

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation.

par Docagne, Fabian;Muñetón, Vilma;Clemente, Diego;Ali, Carine;Loría, Frida;Correa, Fernando;Hernangomez Herrero, Miriam ;Mestre, Leyre;Vivien, Denis;Guaza, Carmen
Référence Molecular and cellular neurosciences, 34, 4, page (551-561)
Publication Publié, 2007-04

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation.
Auteur:	Docagne, Fabian; Muñetón, Vilma; Clemente, Diego; Ali, Carine; Loría, Frida; Correa, Fernando; Hernangomez Herrero, Miriam; Mestre, Leyre; Vivien, Denis; Guaza, Carmen
Informations sur la publication:	Molecular and cellular neurosciences, 34, 4, page (551-561)
Statut de publication:	Publié, 2007-04
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Animals
	Blotting, Western
	Cannabinoids -- therapeutic use
	Demyelinating Diseases -- pathology -- prevention & control
	Disease Models, Animal
	Electrophoresis, Polyacrylamide Gel
	Excitatory Amino Acid Antagonists -- therapeutic use
	Female
	Immunohistochemistry
	Mice
	Multiple Sclerosis, Chronic Progressive -- drug therapy -- pathology
	Neuroprotective Agents -- therapeutic use
	Quinoxalines -- therapeutic use
	Receptor, Cannabinoid, CB1 -- drug effects -- metabolism
	Receptor, Cannabinoid, CB2 -- drug effects -- metabolism
	Spinal Cord -- drug effects -- pathology
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:1044-7431
	info:doi/10.1016/j.mcn.2006.12.005
	info:pii/S1044-7431(06)00290-9
	info:pmid/17229577